Skip to main content
Journal cover image

Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial

Publication ,  Conference
Colon-Emeric, CS; Eriksen, EF; Lyles, KW; Pieper, CF; Magaziner, JS; Adachi, JD; Hyldstrup, L; Recknor, C; Nordsletten, L; Lavecchia, C; Hu, H ...
Published in: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
April 1, 2008

Duke Scholars

Published In

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

ISSN

0002-8614

Publication Date

April 1, 2008

Volume

56

Issue

4

Start / End Page

S17 / S17

Location

Washington, DC

Publisher

BLACKWELL PUBLISHING

Conference Name

Annual Meeting of the American-Geriatrics-Society

Related Subject Headings

  • Geriatrics
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Colon-Emeric, C. S., Eriksen, E. F., Lyles, K. W., Pieper, C. F., Magaziner, J. S., Adachi, J. D., … Mesenbrink, P. (2008). Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (Vol. 56, pp. S17–S17). Washington, DC: BLACKWELL PUBLISHING.
Colon-Emeric, C. S., E. F. Eriksen, K. W. Lyles, C. F. Pieper, J. S. Magaziner, J. D. Adachi, L. Hyldstrup, et al. “Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial.” In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 56:S17–S17. BLACKWELL PUBLISHING, 2008.
Colon-Emeric CS, Eriksen EF, Lyles KW, Pieper CF, Magaziner JS, Adachi JD, et al. Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. BLACKWELL PUBLISHING; 2008. p. S17–S17.
Colon-Emeric, C. S., et al. “Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial.” JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, vol. 56, no. 4, BLACKWELL PUBLISHING, 2008, pp. S17–S17.
Colon-Emeric CS, Eriksen EF, Lyles KW, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. BLACKWELL PUBLISHING; 2008. p. S17–S17.
Journal cover image

Published In

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

ISSN

0002-8614

Publication Date

April 1, 2008

Volume

56

Issue

4

Start / End Page

S17 / S17

Location

Washington, DC

Publisher

BLACKWELL PUBLISHING

Conference Name

Annual Meeting of the American-Geriatrics-Society

Related Subject Headings

  • Geriatrics
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences